# Trade Mark Journal No.2026/003 16 January 2026

## WO0000001893609 (1,5,42)

Office of origin: Japan

Date of International Registration:25 July 2025
Date of designation in the UK: 25 July 2025

International priority date claimed: 25 April 2025 (Japan)

Class 1
  Chemicals for use in industry and science; diagnostic reagents for scientific or research use; biological preparations, other than for medical or veterinary use; chemical reagents, other than for medical or veterinary purpose; biochemical reagents used for non-medical purposes; diagnostic reagents and preparations, except for medical or veterinary use; chemical reagents for use in genetic research, other than for medical or veterinary use; chemicals and biochemical products for use in gene delivery technology, other than for medical or veterinary use; active chemical ingredients for use in the manufacture of pharmaceuticals; viruses, other than for medical and veterinary purposes; viral vectors, other than for medical and veterinary purposes; nucleic acid sequences, other than for medical or veterinary purposes.
Class 5
  Drugs for medical purposes; therapeutic drugs and agents; chemotherapeutics; organotherapy preparations; biological preparations for medical purposes; biological preparations for gene therapy; reagents for medical or veterinary purposes; antibodies for medical or veterinary purposes; drug delivery agents; viral vectors for medical use relating to gene therapy; gene therapy preparations for neurological diseases; pharmaceutical preparations acting on the central nervous system; nucleic acid sequences for medical and veterinary purposes; cells for medical or clinical use; enzymes for medical purposes.
Class 42
  Medical research; chemical research; chemistry services; chemical analysis; clinical trials; testing, inspection or research of pharmaceuticals; gene therapy research; development of gene-based medicines; research and development services relating to medicines; research and development in the field of biotechnology; development of new technology for others in the field of medicine, science, and chemistry; research and development of new products for others; laboratory services for biomanufacturing; scientific research; providing information about medical and scientific research in the field of pharmaceuticals; research and development services in the field of platform technologies for genetic delivery of therapies and pharmaceuticals; consultation and research in the field of gene delivery technology; consultation and research in the field of drug delivery technology; research and development of vaccines; quality control for others.

JCR Pharmaceuticals Co., Ltd.

Representative: SAEGUSA & PARTNERS, Toranomon Daibiru-East Building 9F,, 8-1, Kasumigaseki 3-chome,, Chiyoda-ku, Tokyo 100-0013, JAPAN